228 results

• Doses of Xarelto, Eliquis or Pradaxa in ICU Often Inappropriate: Study

  January 23, 2015

  Irvin Jackson

  A new study reveals that patients are often given inappropriate doses of blood thinners because doctors fail to check kidney functions.

• Xolair Side Effects May Cause Heart Problems, Cancer: FDA Warns

  September 29, 2014

  Austin Kirk

  The FDA is warning that the asthma drug Xolair may increase the risk of blood vessel problems in the brain and heart.

• NuvaRing Warnings Issued for Women Over 35 Who Smoke

  August 4, 2014

  Irvin Jackson

  New warnings about the potential side effects of NuvaRing have been issued, indicating that women over the age of 35 who smoke should not use the vaginal birth control ring.

• Testosterone Drug Risks Subject of FDA Advisory Committee Hearing

  July 18, 2014

  Irvin Jackson

  The FDA is asking two advisory committees to make recommendations on the prescribing and health risks of testosterone drugs in September.

• Testosterone Blood Clot Warnings Added for DVT, Pulmonary Embolism

  June 23, 2014

  Irvin Jackson

  All testosterone drugs will now carry a new general warning that they increase the risk of blood clots, the FDA has announced.

• NuvaRing Settlement to Move Forward for 3,800 Plaintiffs

  June 9, 2014

  Austin Kirk

  The $100 million NuvaRing settlement agreement announced early this year will move forward, after Merck confirmed that they will not opt-out of the agreement since only an "immaterial number" of plaintiffs have not agreed to participate.

• IVC Filters Should Be Removed Once Need Has Passed, FDA Warns

  May 8, 2014

  Irvin Jackson

  The FDA has determined that IVC filters should be removed between 29 and 54 days after being implanted to reduce the risk of fracturing inside the body.

• Bayer Continues to Face About 3,900 Unsettled Yaz, Yasmin Lawsuits

  April 30, 2014

  Austin Kirk

  Bayer continues to face nearly 4,000 of Yaz and Yasmin birth control pill claims, after agreeing to pay more than $1.74 billion to settle nearly 18,000 cases.

• Low T Drug Class Action Filed for Users of Androderm, Depo-Testosterone

  April 17, 2014

  Irvin Jackson

  A Pennsylvania couple is calling for a class action lawsuit against the makers of AndroDerm and Depo-Testosterone low T drugs.

• Amid Bleeding Concerns, Pradaxa Approval Expanded for New Indication

  April 10, 2014

  Irvin Jackson

  The FDA has agreed to expand the use of Pradaxa to include prevention of DVT and pulmonary embolism, with the decision coming amid continuing concerns about the risk of uncontrollable bleeding problems associated with a lack of reversal agent.